ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Guest Opinion: Long Island Study’s Value Now Rests In Its Repository

November 2, 2002

Panel Urges New Research Consortium For Stomach, Esophageal Cancers

January 17, 2003

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

Obituary: Selma Schimmel, Founder of Vital Options, Dies of Cancer

May 23, 2014

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013